AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
AGE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.38%38.950.9%$1259.62m
JNJJohnson & Johnson 0.40%148.990.7%$900.02m
MRKMerck & Co., Inc. -0.22%81.450.6%$641.25m
ABBVAbbVie, Inc. 0.38%93.581.9%$601.86m
BMYBristol-Myers Squibb Co. 3.37%61.701.0%$588.48m
AZNAstraZeneca Plc 0.45%56.191.2%$579.16m
LLYEli Lilly & Co. -0.01%154.391.1%$446.85m
NVSNovartis AG -0.07%83.420.2%$138.06m
GSKGlaxoSmithKline Plc -0.70%40.920.2%$134.47m
OPKOPKO Health, Inc. 0.37%5.4711.2%$129.66m
MISTMilestone Pharmaceuticals, Inc. -0.67%8.900.0%$120.95m
RGENRepligen Corp. 0.00%155.887.1%$69.92m
NVONovo Nordisk A/S -1.65%63.990.1%$65.28m
PRNBPrincipia Biopharma, Inc. 5.12%90.070.0%$60.63m
IMRNImmuron Ltd. 2.37%11.210.0%$54.08m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.